How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Monofilament Polyamide Suture Market
- By Suture Size: USP 6-0, USP 5-0, USP 4-0, USP 3-0, USP 2-0
- By Suture Length: 45 cm, 70 cm, 90 cm, 150 cm
- By Needle Type: Reverse Cutting Needle, Taper Point Needle, Conventional Cutting Needle, Blunt Point Needle
- By Application: General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynecological Surgery, Ophthalmic Surgery
- By Packaging Type: Single Sterile Pack, Multi-Pack Sterile, Bulk Packaging
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - USP 6-0 leads By Suture Size at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Monofilament Polyamide Suture Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Suture Size 5
Suture Length 4
Needle Type 4
Application 5
Packaging Type 3
Companies profiled
Ethicon (Johnson & Johnson)
Medtronic
B. Braun Melsungen AG
Teleflex Incorporated
Smith & Nephew
Sutures India Pvt. Ltd.
Halyard Health (now part of Owens & Minor)
Covidien (now part of Medtronic)
Conmed Corporation
Braun Surgical S.A.
Assut Europe
Surgical Specialties Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Ethicon (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smith & Nephew
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Sutures India Pvt. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Halyard Health (now part of Owens & Minor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Covidien (now part of Medtronic)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Conmed Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Braun Surgical S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Assut Europe
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Surgical Specialties Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Aesculap (B. Braun)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Supa Medical Devices
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Safil Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,524M by 2033 · 8.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- USP 6-033.6
- USP 5-012.6
- USP 4-019.5
- USP 3-013.7
- USP 2-020.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$427.6M → $822.9M · 8.5%
Europe$298.1M → $524.3M · 7.3%
Asia Pacific$272.1M → $472.7M · 7.1%
Latin America$168.5M → $345.5M · 9.4%
Middle East and Africa$129.6M → $280.9M · 10.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.642026
8.662027
8.672028
8.682029
8.692030
8.702031
8.722032
8.732033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Ethicon (Johnson & Johnson)16.7
- Medtronic26.4
- B. Braun Melsungen AG4.0
- Teleflex Incorporated10.2
- Smith & Nephew9.9
- Sutures India Pvt. Ltd.4.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Suture Size20.6%
Suture Length12.4%
Needle Type22.3%
Application22.2%
Packaging Type22.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe21.4
- Asia Pacific19.3
- Latin America14.1
- Middle East and Africa11.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Ethicon (Johnson & Johnson) | 74 | 85 | 94 | 77 | 80 | 93 | 84 |
| Medtronic | 83 | 92 | 78 | 85 | 69 | 91 | 83 |
| B. Braun Melsungen AG | 72 | 68 | 78 | 84 | 70 | 64 | 73 |
| Teleflex Incorporated | 81 | 77 | 75 | 79 | 63 | 64 | 73 |
| Smith & Nephew | 65 | 75 | 60 | 57 | 65 | 76 | 66 |
| Sutures India Pvt. Ltd. | 69 | 52 | 67 | 49 | 48 | 57 | 57 |
| Halyard Health (now part of Owens & Minor) | 60 | 44 | 41 | 53 | 63 | 59 | 53 |
| Covidien (now part of Medtronic) | 50 | 49 | 52 | 44 | 55 | 56 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Ethicon (Johnson & Johnson)
- Medtronic
- B. Braun Melsungen AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Ethicon (Johnson & Johnson) | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Medtronic | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| B. Braun Melsungen AG | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Teleflex Incorporated | ✓ | ◐ | ◐ | ✓ | ◐ | − |
| Smith & Nephew | ◐ | ◐ | − | − | ✓ | ◐ |
| Sutures India Pvt. Ltd. | − | ◐ | − | − | − | ◐ |
| Halyard Health (now part of Owens & Minor) | ◐ | − | − | − | − | − |
| Covidien (now part of Medtronic) | ◐ | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Ethicon (Johnson & Johnson)84
2Medtronic83
3B. Braun Melsungen AG73
4Teleflex Incorporated73
5Smith & Nephew66
6Sutures India Pvt. Ltd.57
7Halyard Health (now part of Owens & Minor)53
8Covidien (now part of Medtronic)51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Ethicon (Johnson & Johnson)Medtronic
Challenger2
Strong scale, closing on the leaders.
B. Braun Melsungen AGTeleflex Incorporated
Contender2
Focused players with pockets of strength.
Smith & NephewSutures India Pvt. Ltd.
Niche2
Specialists in a single segment or region.
Halyard Health (now part of Owens & Minor)Covidien (now part of Medtronic)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Suture Size in North America, then scale across Monofilament Polyamide Suture Market — a $495M beachhead inside a $9.06B market.
Beachhead (SOM)$495Mobtainable near-term
Serviceable (SAM)$3.33Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
USP 6-0
Best fit — highest urgency & budget in Suture Size.
Economic buyer77 fit
USP 5-0
Strong fit — clear ROI and a fast path to value.
End user64 fit
USP 4-0
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Suture Size in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Suture Length & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Needle Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Suture Size leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Monofilament Polyamide Suture Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified25%
Evaluation14%
Closed-won6%
$10.4KCAC
$62KLTV
5.9:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Monofilament Polyamide Suture Market is a durable-growth opportunity — $8.98B by 2033, compounding at 9.3%.
TAM · 2025$4.41Btoday
TAM · 2033$8.98Bforecast
CAGR9.3%2027–2033
Cumulative$58.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.98BTotal addressable market
SAM$3.77BServiceable available market
SOM$814MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Suture Size.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Suture Size moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.98BLarge & growingTAM by 2033 at 9.3% CAGR
$3.77BServiceable nowreachable with today’s model
$814MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.00BBear6.0% CAGR
$8.98BBase9.3% CAGR
$11.5BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Suture Length optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Monofilament Polyamide Suture Market — a $7.80B market by 2033. Plan: grow share from 7.6% to 14.1%.
Market size · 2033$7.80Btotal addressable
Market CAGR8.8%2027–2033
Target share14.1%from 7.6% today
Revenue ambition$1.10Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 14.1% | Ahead |
| Revenue | $645M | $1.10B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.7% | 38.1% | On track |
| Customer retention | 85.5% | 95.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Suture Size
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Suture Length capability
A defensible second engine — invest in Suture Length to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Suture Size share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Suture Length
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $150M capacity & capability investment
- Greenlight bolt-on M&A in Suture Length
- Authorise North America expansion plan
- Fund R&D program for Suture Size leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Monofilament Polyamide Suture Market conversation — a $3.33B market you can size, segment and defend in minutes.
Market size · 2033$3.33Btotal opportunity
Growth8.3%CAGR to 2033
Addressable buyers1,363+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Suture Size
Goal Grow share in Suture Size
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 2 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Ethicon (Johnson & Johnson)MedtronicB. Braun Melsungen AGTeleflex IncorporatedSmith & NephewSutures India Pvt. Ltd.Halyard Health (now part of Owens & Minor)Covidien (now part of Medtronic)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Monofilament Polyamide Suture Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Monofilament Polyamide Suture Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Monofilament Nylon Suture Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportMonofilament Absorbable Suture Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportMonodose Packaging for Probiotics and Nutraceutical Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportMonocyte Chemotactic Protein 1 (MCP-1) ELISA Kit Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportMonocyte Activation Test Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportMonocular Indirect Funduscopy Market
Market size, share, segmentation and regional forecast.
$332M market · 2025 base year
View reportMonoclonal Gammopathy of Undetermined Significance (MGUS) Treatment Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportMonoclonal Antibody Therapy for Treatment of ALL Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportMonoclonal Antibody Reagent Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportMonoclonal Antibody Medicine Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMonoclonal Antibody Drug Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportMonoclonal Antibody Development Services Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.